We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-20.47%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$9.64B
AUM Growth
-$2.48B
Cap. Flow
+$636M
Cap. Flow %
6.6%
Top 10 Hldgs %
42.18%
Holding
1,253
New
58
Increased
575
Reduced
265
Closed
42

Top Buys

Rank Stock Value
1
PSA icon
Public Storage
PSA
+$250M
2
SPG icon
Simon Property Group
SPG
+$213M
3
VTR icon
Ventas
VTR
+$180M
4
KRMA
Global X Conscious Companies ETF
KRMA
+$147M
5
STOR
STORE Capital Corporation
STOR
+$132M

Top Sells

Rank Stock Value
1
O icon
Realty Income
O
+$178M
2
PEB icon
Pebblebrook Hotel Trust
PEB
+$99.3M
3
EQIX icon
Equinix
EQIX
+$96.7M
4
DEI icon
Douglas Emmett
DEI
+$88.8M
5
CONE
CyrusOne Inc Common Stock
CONE
+$84.5M

Sector Composition

Rank Sector Weight
1 Real Estate 70.9%
2 Technology 5.34%
3 Financials 3.16%
4 Healthcare 3.13%
5 Industrials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDUS
1126
DELISTED
Radius Health, Inc.
RDUS
$3K ﹤0.01%
261
– –
TBIO
1127
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$3K ﹤0.01%
287
– –
PTLA
1128
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$3K ﹤0.01%
439
– –
ANAB icon
1129
AnaptysBio
ANAB
$1.54B
$2K ﹤0.01%
172
– –
ASMB icon
1130
Assembly Biosciences
ASMB
$498M
$2K ﹤0.01%
12
– –
BCRX icon
1131
BioCryst Pharmaceuticals
BCRX
$2.42B
$2K ﹤0.01%
869
– –
CRBP icon
1132
Corbus Pharmaceuticals
CRBP
$165M
$2K ﹤0.01%
14
– –
CTMX icon
1133
CytomX Therapeutics
CTMX
$690M
$2K ﹤0.01%
285
– –
DTIL icon
1134
Precision BioSciences
DTIL
$178M
$2K ﹤0.01%
10
– –
MCRB icon
1135
Seres Therapeutics
MCRB
$45M
$2K ﹤0.01%
22
– –
MGNX icon
1136
MacroGenics
MGNX
$233M
$2K ﹤0.01%
310
– –
PBYI icon
1137
Puma Biotechnology
PBYI
$398M
$2K ﹤0.01%
243
– –
PRTA icon
1138
Prothena Corp
PRTA
$448M
$2K ﹤0.01%
212
– –
SIGA icon
1139
SIGA Technologies
SIGA
$240M
$2K ﹤0.01%
511
– –
SRRK icon
1140
Scholar Rock
SRRK
$5.88B
$2K ﹤0.01%
168
– –
TXMD icon
1141
TherapeuticsMD
TXMD
$23.8M
$2K ﹤0.01%
31
– –
UBX
1142
DELISTED
Unity Biotechnology
UBX
$2K ﹤0.01%
27
– –
URGN icon
1143
UroGen Pharma
URGN
$1.97B
$2K ﹤0.01%
118
– –
VYGR icon
1144
Voyager Therapeutics
VYGR
$181M
$2K ﹤0.01%
232
– –
WVE icon
1145
Wave Life Sciences
WVE
$1.12B
$2K ﹤0.01%
213
– –
SYRS
1146
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2K ﹤0.01%
27
– –
GTHX
1147
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$2K ﹤0.01%
212
– –
BCEL
1148
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$2K ﹤0.01%
124
– –
ORTX
1149
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$2K ﹤0.01%
31
+9
+41% +$1.04K
AMRS
1150
DELISTED
Amyris Inc.
AMRS
$2K ﹤0.01%
645
– –
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2020 Portfolio in Review

As of Q1 2020, Daiwa Securities Group held 1,253 positions worth $9.64B, down 20% from $12.1B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Daiwa Securities Group deployed $636M of net new capital in Q1 2020, opening 58 new positions and adding to 575 existing holdings. Its largest new stake was Global X Conscious Companies ETF: 6,650,000 shares worth $122M.

By sector, the portfolio is most concentrated in Real Estate at 71% of assets, down from 73% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Realty Income, an estimated $178M trimmed.

  • Daiwa Securities Group's largest Q1 2020 buy was Global X Conscious Companies ETF: 6,650,000 shares worth $122M.
  • Daiwa Securities Group added most to Public Storage in Q1 2020, an estimated $250M increase.
  • Daiwa Securities Group's biggest Q1 2020 reduction was Realty Income, cutting an estimated $178M.
  • Daiwa Securities Group fully exited RTX Corp in Q1 2020, selling an estimated $10.1M.
  • Daiwa Securities Group's ten largest holdings make up 42% of its $9.64B portfolio in Q1 2020.
  • Daiwa Securities Group opened 58 new positions and closed 42 in Q1 2020.
  • Daiwa Securities Group's portfolio value fell 20% quarter-over-quarter to $9.64B.

Based on Daiwa Securities Group's 13F filing for Q1 2020, filed 14 May 2020.